EV Biologics Corp, OTC Pink:YECO, today briefed shareholders on its current value compared to other public biotechnology companies in its peer group. Please view the… Read More »EV Biologics Briefs Shareholders on Market Cap Peer Comparison
EV Biologics Corp, OTC PINK:YECO, today updated shareholders with further details about its NFT Warrant Dividend. Attached is a preliminary image from the 3D animation… Read More »EV Biologics NFT Dividend Information
EV Biologics Corp, OTC PINK:YECO today announced that it has signed an agreement with Lonza Cell Bio Services to implement a custom cell isolation in… Read More »EV Biologics Starts Custom Cell Isolation with Lonza Cell Bio Services
EV Biologics Corp, OTC PINK:YECO, today updated shareholders about its NFT dividend Warrant. The Company will distribute one (1) Warrant for every 100 shares of… Read More »EV Biologics Unveils NFT Dividend Warrant
EV Biologics Corp., (OTC PINK:YECO) today announced that it has signed a Letter of Intent (LOI) with Lonza Cell & Gene Therapy for Process Development… Read More »EV Biologics Signs LOI with Lonza Cell & Gene Therapy
EV Biologics Corp, OTC PINK:YECO, today updated shareholders about its NFT dividend. On July 14, 2021 the Company announced a dividend of 1 NFT for… Read More »EV Biologics NFT Dividend Update
EV Biologics Corp, OTC PINK:YECO, today announced that it will distribute a dividend of one (1) Non-Fungible Token (NFT) for every 100 shares of YECO… Read More »EV Biologics Announces NFT Dividend
EV Biologics Corp (OTC PINK:YECO) today announced that it has completed all its filings on OTC Markets and is now Pink Current. Being current and… Read More »EV Biologics is now Pink Current
EV Biologics Corp., OTC PINK:YECO, is taking this opportunity to update our shareholders and other investors concerning the status of our name change submission to… Read More »EV Biologics Updates Shareholders on Name and Symbol Change
EV Biologics Corp (OTC PINK:YECO) today announced that it has signed a director’s loan agreement to secure funding of up to $5 million to start… Read More »EV Biologics Confirms Funding to Commence Cell Line Generation & Advance Exosome Research
